(Q33396013)

26 July 2017

title

Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations (English)

1 reference

26 July 2017

1 reference

2

Tim H J Goodship

1 reference

26 July 2017

4

Carol Inward

1 reference

26 July 2017

Jon Jin Kim

1

1 reference

26 July 2017

Jane Tizard

series ordinal

3

1 reference

26 July 2017

publication date

30 June 2011

1 reference

26 July 2017

1 reference

26 July 2017

volume

26

1 reference

26 July 2017

issue

11

1 reference

26 July 2017

page(s)

2073-2076

1 reference

aHUS caused by complement dysregulation: new therapies on the horizon

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1944-4

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1944-4

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1944-4

The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1944-4

The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1944-4

Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1944-4

Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1944-4

Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1944-4

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1944-4

Complement factor H-associated atypical hemolytic uremic syndrome in monozygotic twins: concordant presentation, discordant response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1944-4

Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1944-4

Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1944-4

Severe atypical HUS caused by CFH S1191L--case presentation and review of treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1944-4

Atypical relapse of hemolytic uremic syndrome after transplantation

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21717289

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Challenges in the management of infantile factor H associated hemolytic uremic syndrome.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21717289

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00467-011-1944-4

1 reference

Dimensions Publication ID

26 July 2017

1043714820

0 references

1 reference